Dr. Bella Mehta

Joining the discussion are Bella Mehta, a New York rheumatologist specializing in autoimmune diseases, Brian Jaros from Chicago, an expert in giant cell arteritis, and Quilin Conley from Galway, focusing on anti-obesity medications. They delve into new lupus nephritis recommendations and explore the interplay between psoriatic arthritis and immunotherapy mortality risks. Additionally, advancements in predicting vision loss in giant cell arteritis are discussed, alongside the potential of GLP-1 medications to benefit rheumatoid arthritis patients, despite challenges like side effects.

Dr. Amanda Nelson, a rheumatologist and epidemiologist specializing in osteoarthritis and machine learning, joins Dr. Bella Mehta, an academic rheumatologist focused on health disparities and big data, to discuss the transformative role of AI in healthcare. They explore AI's potential in enhancing diagnostic accuracy, patient personalization through digital twins, and the analysis of medical images using deep learning. The conversation navigates the promise of AI in rheumatology while addressing ethical considerations and the need for careful oversight to ensure equitable and effective use.